News
A clinical trial has shown that Ozempic improves blood glucose levels and weight loss in overweight type 1 diabetics who use ...
Blue Earth Therapeutics today announced radiation dosimetry results for its radiohybrid lutetium labelled, PSMA targeted, ...
2h
News-Medical.Net on MSNTirzepatide rewires appetite and slashes calorie intake in new obesity trialA 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...
More than 100 dogs are being recruited for a world-first cannabis clinical trial to help canines suffering from ...
In a clinical trial led by University of Toronto researchers, an allogeneic stem cell–derived islet therapy (zimislecel) ...
Discover how young healthcare innovators from Durban are transforming clinical trials and community health, earning accolades ...
Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...
Anixa Biosciences advances CAR T-cell therapy for recurrent ovarian cancer, targeting FSHR with promising safety and efficacy ...
A phase 3 clinical trial investigating ST-100 for the treatment of dry eye disease did not meet its primary endpoint but ...
During a routine doctor's visit, Myers was informed she had only three years left to live due to Von Hippel-Lindau syndrome, ...
A clinical study reveals that consuming two ounces of pecans daily significantly reduces LDL cholesterol levels.
Brian Ongioni, chief product officer, uMotif, discusses how AI and machine learning can enhance patient-reported outcomes by capturing meaningful feedback at scale and ensuring patient voices are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results